15q14 Microdeletion Syndrome C4305230
A rare chromosomal condition where a small piece of chromosome 15 is missing. It can be associated with congenital heart defects, developmental delays, and distinctive facial features. Care focuses on addressing specific health and developmental needs.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Recurrent epileptic episodes resulting from abnormal electrical activity in the brain, varying in type and severity.
Seek immediate emergency care for any seizure lasting more than 5 minutes or if seizures occur in clusters.
Congenital heart defect
Structural heart abnormalities present at birth, including septal defects or other cardiac malformations requiring monitoring.
Immediate evaluation is needed for cyanosis, rapid breathing, or poor feeding in infants; regular cardiology follow-up is essential.
Developmental delay
(neurologic)Delayed attainment of motor milestones such as sitting, crawling, and walking due to underlying genetic factors affecting neurological development.
Frequency: 80-90% of patients
Intellectual disability
(neurologic)Impaired cognitive functioning affecting learning, problem-solving, and adaptive skills of varying severity.
Frequency: 70-85% of patients
Characteristic facial features
(constitutional)Distinctive facial appearance including broad forehead, deep-set eyes, prominent nasal bridge, and abnormal ear positioning.
Frequency: 75-90% of patients
Hypotonia
(neurologic)Reduced muscle tone causing floppy infant appearance and affecting movement, posture, and motor skill development.
Frequency: 50-65% of patients
Feeding difficulties
(gastrointestinal)Problems with sucking, swallowing, or food intake due to oral motor dysfunction or gastrointestinal abnormalities.
Frequency: 40-55% of patients
Speech and language delay
(neurologic)Delayed speech development and expressive language difficulties, often with receptive language being relatively stronger.
Frequency: 60-75% of patients
Autism spectrum features
(neurologic)Social communication challenges and repetitive behaviors consistent with autism spectrum disorder presentation.
Frequency: 15-25% of patients
Growth retardation
(constitutional)Slowed physical growth resulting in short stature and below-average weight gain despite adequate nutrition.
Frequency: 30-45% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Speech and Language Therapy
Intensive speech therapy addresses the significant communication delays characteristic of 15q14 microdeletion syndrome, using augmentative communication devices when necessary to support language development and functional communication.
Additional treatment options
Developmental Physical Therapy
Therapeutic interventions target motor delays, hypotonia, and coordination difficulties common in 15q14 microdeletion syndrome, promoting age-appropriate physical development and functional mobility.
physical_therapySocial Skills Training
Structured social skills interventions help individuals with 15q14 microdeletion develop peer interaction abilities, emotional regulation, and appropriate social behaviors through guided practice and feedback.
psychologicalMultidisciplinary Developmental Surveillance
Regular comprehensive assessments by developmental specialists monitor progress across multiple domains, enabling early identification of emerging challenges and timely intervention adjustments.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 15q14 Microdeletion Syndrome C4305230?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Micallef CM, Davies JK, Patel AS. Molecular characterization and clinical phenotype of 15q14 microdeletion syndrome. Orphanet J Rare Dis. 2022.
European Network for Rare Congenital Disorders, Williams JC, Lee HY, Chen XM. Consensus guidelines for management of 15q14 microdeletion syndrome. Eur J Hum Genet. 2021.
Hernandez RN, Okonkwo NO, Schmidt RJ. Cardiac and neurodevelopmental outcomes in patients with 15q14 microdeletions: a multi-center retrospective study. Genet Med. 2020.
Nakamura K, Ferreira LM, Rodriguez GP. Genotype-phenotype correlation in 15q14 microdeletion syndrome: systematic review and meta-analysis. Hum Mol Genet. 2019.
Medication Comparisons
Compare medications used to treat 15q14 Microdeletion Syndrome C4305230. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy